Search

everythinglearnresearchcommunity

for

Search:↓

Ruxolitinib helped a patient with alopecia areata regrow hair.

Xinyang Tablet improves heart function in sepsis by reducing inflammation.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Ginsenoside Re from ginseng may help hair grow by blocking a specific growth-inhibiting pathway.

μ-opiate receptors in skin cells may affect skin health and healing.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Blocking androgen receptors early in life increases estrogen levels and reduces sexual motivation in male rats.

The new treatment using nanoparticles with ISX9 can effectively regrow hair without major side effects.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

PRX102 is essential for rice root hair growth by helping transport substances to the tips.

Using 5-alpha reductase inhibitors may lower the risk of opioid addiction in men taking opioids.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Overexpressing the glucocorticoid receptor in mice leads to abnormal skin development and reduced inflammation.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

The mineralocorticoid receptor temporarily affects mouse skin development, but the glucocorticoid receptor has a more lasting impact.

Blocking the mineralocorticoid receptor improves wound healing by reducing inflammation and promoting blood vessel growth.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Naltrexone shows promise as a safe treatment for a type of hair loss called lichen planopilaris.

Ro 10-9359 is an effective treatment for severe psoriasis but can cause side effects.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.